SCHEMBL7073313

SCHEMBL7073313

O=[N+]([O-])c1ccc2nonc2c1[N+](=O)[O-]

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.68
MEN1 O00255 7/20 0.68
USP2 O75604 1/20 0.68
KEAP1 Q14145 1/20 0.68
NFE2L2 Q16236 1/20 0.68
ARNT P27540 6/20 0.54
EPAS1 Q99814 6/20 0.54
MAPT P10636 4/20 0.54
POLB P06746 4/20 0.50
LMNA P02545 2/20 0.50
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.48
CASP3 P42574 1/20 0.48
RECQL P46063 1/20 0.48
MCL1 Q07820 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28411867 0.98 KMT2A (0.71) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL7089706 0.81 MEN1 (0.66) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL18825636 0.81 KMT2A (0.53) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL3503925 0.81 KMT2A (1.00) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL16111786 0.81 KMT2A (0.66) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL4370339 0.81 KMT2A (0.53) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL14791257 0.81 KMT2A (0.61) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL15716688 0.81 KMT2A (1.00) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL4370342 0.81 MEN1 (0.66) KMT2AMEN1USP2KEAP1NFE2L2
SCHEMBL7052057 0.78 GSTM2 (0.66) KMT2AMEN1USP2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4448107-B1 DRUG DELIVERY SYSTEMS BASED ON ENDOPEROXIDES USEFUL IN DIAGNOSIS AND THERAPY, AND METHODS THEREOF FACULDADE DE FARMACIA DA UNIV DE LISBOA (PT) 2025-11-05 EP claimed
EP-1317242-A1 USE OF 4-NITRO-2,1,3-BENZOXADIAZOL DERIVATIVES AS DYES IN COLOURING AGENTS FOR KERATIN FIBRES Wella Aktiengesellschaft (DE) 2003-06-11 EP disclosed
WO-2002022094-A1 USE OF 4-NITRO-2,1,3-BENZOXADIAZOL DERIVATIVES AS DYES IN COLOURING AGENTS FOR KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2002-03-21 WO disclosed